What is the appropriate acute and long‑term management for an adult with type 2 diabetes presenting with a random blood glucose of about 600 mg/dL (severe uncontrolled hyperglycemia, possible hyperosmolar hyperglycemic state)?

Management of Uncontrolled Type 2 Diabetes with Random Blood Glucose ~600 mg/dL

Immediate Assessment for Hyperosmolar Hyperglycemic State (HHS)

This patient requires urgent evaluation for HHS, a life-threatening emergency with 10–20% mortality that demands immediate hospitalization and aggressive fluid resuscitation. 1, 2

Diagnostic Criteria to Assess NOW:

• Plasma glucose >600 mg/dL (already met) 1, 2
• Effective plasma osmolality >320 mOsm/kg (calculate: 2[Na] + glucose/18 + BUN/2.8) 1, 2
• Venous pH >7.25 and bicarbonate >15 mmol/L (minimal ketoacidosis) 1, 2
• Altered mental status (confusion, lethargy, or coma) 3, 2
• Severe dehydration (dry mucous membranes, poor skin turgor, hypotension, tachycardia) 3, 4

Critical Labs to Order Immediately:

• Serum osmolality, sodium, potassium, BUN, creatinine 3, 4
• Venous blood gas (pH, bicarbonate) 1, 2
• Urine or serum ketones (should be minimal/absent in HHS) 1, 2
• Complete metabolic panel, CBC 3, 4
• ECG (assess for MI, arrhythmias from electrolyte shifts) 3

---

Acute Management if HHS Confirmed (Hospital Setting)

1. Aggressive Fluid Resuscitation (FIRST PRIORITY)

Vigorous correction of dehydration is the cornerstone of HHS treatment—patients typically require 9 liters over 48 hours. 3

• Initial fluid: 0.9% normal saline at 1–1.5 L/hour for the first 1–2 hours until hemodynamically stable 3, 4
• Subsequent fluid: Switch to 0.45% saline at 250–500 mL/hour once blood pressure stabilizes 3, 4
• Goal: Replace 50% of estimated fluid deficit in first 12 hours, remainder over next 24 hours 3, 4
• Monitor: Urine output (goal >0.5 mL/kg/hour), vital signs hourly, serum sodium every 2–4 hours 3, 4

2. Insulin Therapy (AFTER Fluid Resuscitation Started)

Do NOT start insulin until fluid resuscitation is underway—premature insulin can worsen hypotension and precipitate vascular collapse. 3, 4

• Initial bolus: 0.15 units/kg IV (or 0.1 units/kg if using 10–15 unit fixed dose) 3, 4
• Continuous infusion: 0.1 units/kg/hour IV 3, 4
• Target glucose decline: 50–70 mg/dL per hour (NOT faster—risk of cerebral edema) 3, 4
• When glucose reaches 250–300 mg/dL: Add 5% dextrose to IV fluids and reduce insulin to 0.05 units/kg/hour 3, 4
• Goal: Maintain glucose 250–300 mg/dL until osmolality normalizes and patient is alert 3, 4

3. Potassium Replacement (Critical)

Potassium drops precipitously with insulin therapy despite total-body depletion—aggressive replacement prevents life-threatening arrhythmias. 3, 4

• **If K+ <3.3 mEq/L:** Hold insulin, give 20–30 mEq/hour until K+ >3.3 3, 4
• If K+ 3.3–5.0 mEq/L: Add 20–40 mEq/L to each liter of IV fluid 3, 4
• If K+ >5.0 mEq/L: Withhold potassium but recheck every 2 hours 3, 4
• Monitor: Serum potassium every 2–4 hours, continuous cardiac monitoring 3, 4

4. Identify and Treat Precipitating Cause

Underlying infection is the most common trigger—failure to treat the precipitant accounts for the high mortality in HHS. 3, 2

• Infections: Pneumonia, UTI, sepsis (obtain cultures, start empiric antibiotics if suspected) 3, 5
• Medications: Thiazides, corticosteroids, atypical antipsychotics, SGLT2 inhibitors 3, 5
• Acute illness: MI, stroke, pancreatitis, trauma 3, 5
• Non-compliance: Missed insulin doses, undiagnosed diabetes 3, 5

5. Monitor for Complications

• Vascular occlusions: Mesenteric ischemia, MI, stroke, DVT/PE (HHS causes hypercoagulable state) 3
• Cerebral edema: Rare in adults but catastrophic—suspect if headache, altered mental status worsens during treatment 3, 2
• Rhabdomyolysis: Check CK if prolonged immobility or severe dehydration 3
• Hypoglycemia: From overly aggressive insulin—check glucose hourly 3, 4

---

Long-Term Management After Stabilization

Transition from IV to Subcutaneous Insulin

Once patient is eating and osmolality normalizes, transition to basal-bolus regimen 2–4 hours before stopping IV insulin to prevent rebound hyperglycemia. 6

• Calculate total daily dose (TDD): Sum of IV insulin over last 6–8 hours × 4 6
• Basal insulin: 50% of TDD as glargine once daily 6
• Prandial insulin: 50% of TDD divided among 3 meals as lispro/aspart 6
• Example: If patient received 8 units/hour IV × 6 hours = 48 units → TDD ≈ 48 units
  • Glargine 24 units once daily
  • Lispro 8 units before each meal 6

Oral Agent Optimization

Many patients with HHS can eventually be managed without insulin—metformin is the cornerstone of long-term therapy. 1, 3

• Metformin: Start 500 mg BID, titrate to 1000 mg BID (max 2000–2550 mg/day) once renal function stable (eGFR >30) 1, 6
• SGLT2 inhibitor: Add dapagliflozin 10 mg or empagliflozin 10–25 mg for cardiovascular/renal protection 1, 6
• GLP-1 RA: Consider semaglutide 0.5–1 mg weekly if HbA1c remains >7% after 3 months 1, 6
• Insulin weaning: After 2–4 weeks of stability on oral agents, reduce insulin by 10–20% every few days while monitoring glucose 1, 6

Discharge Planning and Follow-Up

• HbA1c <8%: Follow-up with primary care in 1 month 1
• HbA1c 8–9%: Urgent endocrinology referral within 2 weeks 1
• HbA1c >9%: Consider hospitalization in specialized diabetes unit or very close outpatient follow-up (within 1 week) 1
• Patient education: Self-monitoring blood glucose, sick-day management, hypoglycemia recognition, insulin injection technique 6
• Prevent recurrence: Ensure continuous access to medications, diabetes education, regular follow-up 5

---

Key Pitfalls to Avoid

1. Starting insulin before adequate fluid resuscitation → worsens hypotension and can cause cardiovascular collapse 3, 4
2. Correcting glucose too rapidly (>70 mg/dL/hour) → risk of cerebral edema 3, 4
3. Failing to replace potassium aggressively → life-threatening arrhythmias 3, 4
4. Not identifying/treating precipitating cause → accounts for majority of HHS mortality 3, 2
5. Stopping IV insulin before subcutaneous insulin takes effect → rebound hyperglycemia and recurrent HHS 6
6. Using sliding-scale insulin alone after stabilization → ineffective and condemned by guidelines 1, 6
7. Delaying endocrinology referral in patients with HbA1c >9% → prolongs exposure to severe hyperglycemia 1

---

Expected Outcomes

• With appropriate treatment: Mortality 10–20% (vs. <2% for DKA) 2, 5
• Glucose normalization: Typically within 24–48 hours of treatment 3, 4
• Hospital stay: Average 5–7 days for uncomplicated HHS 2
• Long-term insulin requirement: Many patients can transition to oral agents alone after recovery 3, 5
• Recurrence prevention: Patient education and continuous access to care reduce repeat admissions 5